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Summary
Background: Branched actin assembly is critical for both cell
motility and membrane trafficking. The branched actin regu-
lator cortactin is generally considered topromotecellmigration
by controlling leading-edge lamellipodial dynamics. However,
recent reports indicate that lamellipodia are not required for
cell movement, suggesting an alternate mechanism.
Results: Because cortactin also regulates membrane traf-
ficking and adhesion dynamics, we hypothesized that altered
secretion of extracellular matrix (ECM) and/or integrin traf-
ficking might underlie motility defects of cortactin-knockdown
(KD) cells. Consistent with a primary defect in ECM secretion,
both motility and lamellipodial defects of cortactin-KD cells
were fully rescued by plating on increasing concentrations of
exogenous ECM. Furthermore, cortactin-KD cell speed
defects were rescued on cell-free autocrine ECM produced
by control cells, but not on ECM produced by cortactin-KD
cells. Investigation of the mechanism revealed that whereas
endocytosed fibronectin (FN) is redeposited at the basal cell
surface by control cells, cortactin-KD cells exhibit defective
FN secretion and abnormal FN retention in a late endocytic/
lysosomal compartment. Cortactin-KDmotility and FNdeposi-
tion defects were phenocopied by KD in control cells of the
lysosomal fusion regulator synaptotagmin-7. Rescue of cor-
tactin-KD cells by expression of cortactin-binding domain
mutants revealed that interaction with the Arp2/3 complex
and actin filaments is essential for rescue of both cell motility
and autocrine ECM secretion phenotypes, whereas binding
of SH3-domain partners is not required.
Conclusions: Efficient cell motility, promoted by cortactin
regulation of branched actin networks, involves processing
and resecretion of internalized ECM from a late endosomal/
lysosomal compartment.
Introduction
Cell motility is a fundamental component of many physiolog-
ical and pathological processes, including embryogenesis,
wound healing, and cancer metastasis. Intrinsic cell motility
cycles canonically consist of protrusion of leading-edge lamel-
lipodia, formation of new adhesions, cell body contraction,
and tail detachment. These cycles are modified by cellular
interaction with extrinsic factors, including growth factors
and extracellular matrix (ECM) [1]. A motility molecule that
has received a great deal of attention is cortactin, as a result*Correspondence: alissa.weaver@vanderbilt.eduof its presence in leading-edge lamellipodia and its function
as a regulator of the actin-nucleating Arp2/3 complex [2].
Numerous studies have shown that cortactin regulates cell
migration in diverse cell types [3], including Drosophila border
cells migrating in vivo [4]. In contrast, some other reports have
found little or no effect of cortactin expression on cell migra-
tion, suggesting either cell type or microenvironmental influ-
ences [5, 6].
The underlying mechanism for cortactin regulation of cell
motility has been variably attributed to regulation of Arp2/3-
mediated branched actin dynamics in leading-edge protru-
sions or to regulation of signaling [2, 7, 8]. However, a number
of studies have found that cortactin is not essential for lamelli-
podial protrusion but rather affects lamellipodial dynamics [3].
In addition, lamellipodial protrusion has been shown to be
dispensable for cell movement [9], suggesting that lamellipo-
dial protrusion may serve primarily to direct the cell rather
than drive the actual mechanics of intrinsic cell motility. By
contrast, adhesion of cells to ECM is known to be critical for
cell motility [1, 10].
Previously, we identified specific defects in both lamellipo-
dial persistence (e.g., stability) and adhesion assembly in
cortactin-knockdown (KD) cells [7] that were coordinately
rescued along with cell motility by a minimal cortactin trunca-
tion protein that contained the Arp2/3 complex and F-actin
binding sites. Interestingly, lamellipodial persistence defects
are frequently associated with primary defects in integrin
activity or expression [11–13], which suggests that the adhe-
sion assembly defect of cortactin-KD cells might cause lamel-
lipodial instability rather than vice versa. Because cortactin is
known to regulate membrane trafficking [3], we hypothesized
that the lamellipodial, adhesion, and motility defects observed
in cortactin-deficient cells [3] could be a consequence of
defective ECM secretion or altered integrin trafficking.
Indeed, in this study we report that cortactin-KD cells exhibit
decreased fibronectin (FN) secretion that leads to defects in
cell motility and lamellipodial dynamics. Interestingly, investi-
gation of the mechanism revealed that, dependent on cortac-
tin interaction with branched actin networks, exogenous FN is
internalized and resecreted from a late endocytic/lysosomal
compartment to promote efficient cell motility.
Results
The goal of this study was to test the hypothesis that cortactin
regulates cell motility by altering membrane trafficking of
either ECM components or integrins. Such a mechanism
would link twomajor cellular functions (migration and vesicular
trafficking) described for cortactin andmight explain divergent
reports on the role of cortactin in cell motility.
Migration and Lamellipodial Defects of Cortactin-KD Cells
Are Rescued on Exogenous ECM
If cortactin primarily regulates motility through autocrine
secretion of ECM, then the defective motility of cortactin-KD
cells should be rescued by performing cell motility assays on
ECM-coated surfaces. To test this possibility, we coated seri-
ally diluted FN or collagen I on the bottom of tissue culture
Figure 1. Cortactin-Knockdown Cell Motility
and Lamellipodial Defects Are Rescued on
Substrates Coated with Exogenous Extracellular
Matrix
(A and C) Single-cell migration assays on fibro-
nectin-coated (A) or collagen-coated (C) plates.
The following abbreviations are used: Sc,
scrambled oligo; KD, cortactin-knockdown; OE,
cortactin-overexpressing; Res, rescued (KD cells
re-expressing shRNA-insensitive mouse cortac-
tin). nR 45 cells from three independent experi-
ments for each cell line.
(B and D) Transwell migration assays on fibro-
nectin-coated (B) or collagen-coated (D) trans-
well filters. Four different fields were observed
in each of three independent experiments.
(E) Representative kymographs on uncoated or
fibronectin-coated (FN; 10 mg/ml) plates. Note
definitions of lamellipodial persistence (length of
time that a protrusion lasts before retraction,
Dx), protrusion distance (Dy2), and protrusion
speed (initial rate, Dy1/Dx1). Scale bars indicate
distance and time axes.
(F–I) Quantitation of lamellipodial persistence (F),
protrusion distance (G), protrusion speed (H), and
retraction speed (I). n R 20 cells from three or
more independent experiments.
*p < 0.05; **p < 0.01; ***p < 0.001 compared to Sc.
Error bars indicate standard error of the mean
(SEM).
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1461plates for single-cell (Figures 1A and 1C) or transwell mem-
branes for transwell (Figures 1B and 1D) migration assays.
As reported previously [7], in the absence of exogenous
ECM, cortactin-KD HT1080 fibrosarcoma cells migrated
less efficiently than scrambled oligo-expressing control cells(scrambled) or KD cells rescued with
short hairpin RNA (shRNA)-insensitive
mouse cortactin cDNA (Res), whereas
cortactin-overexpressing (OE) cells
migrated faster (Figures 1A and 1B,
0 mg/ml FN; see Figure S1A available on-
line for cortactin protein abundance).
However, plating cells on increasing
concentrations of FN or collagen I led
to full rescue of cortactin-KD motility
defects to the level of control cells
(Figures 1A–1D) at higher ECM concen-
trations. Similarly, single-cell motility
defects of cortactin-KD MDA-MB-231
breast cancer cells were rescued by
plating cells on the highest tested
concentrations of FN or collagen I (Fig-
ure S1). There was much less effect of
exogenous ECM on control and OE cell
speed, suggesting a more optimal
ECM-adhesion axis [10] on uncoated
surfaces as might occur with autocrine
secretion of ECM. These data suggest
an extrinsic and not intrinsic motility
defect in cortactin-KD cells.
We previously reported that cortactin-
KD cells have defective stability and
persistence of lamellipodial protrusions
that parallel the motility defects [7]. To
analyze the effect of exogenous ECMon lamellipodial dynamics, we recorded membrane ruffling of
cortactin-manipulated HT1080 cells plated on 0 or 10 mg/ml
FN in time-lapse movies and performed analysis by kymog-
raphy [7, 14] (Figure 1E). Consistent with the migration assays,
the lamellipodial persistence defect of cortactin-KD cells [7]
Figure 2. Cortactin Expression Affects Adhesion Formation on Low-Extracellular Matrix Substrates but Not Total or Cell Surface Levels of b1 Integrin
(A) Western blot analysis of total cell lysates from scrambled control (Sc), cortactin-KD (KD), and cortactin-rescued (Res) HT1080 cells shows no difference
in total cell b1 integrin levels. Representative blot from n = 2 experiments.
(B) Flow cytometry analysis shows no difference in b1 cell-surface expression. Representative profiles are shown. The following abbreviations are used: C,
control IgG; b1, integrin b1. n = 2 experiments.
(C) Representative TIRF images of activated (visualized using 12G10 mAb staining) integrin b1 at basal surface of cells cultured on poly-D-lysine-coated
(PDL; 100 mg/ml) or FN-coated (10 mg/ml) glass surfaces. Cell boundaries fromdifferential interference contrast (DIC) images (Figure S2) are outlined inwhite.
Scale bar represents 30 mm.
(D) Quantitation of activated integrin b1-positive area per cell and intensity per cell calculated with or without (w/o) thresholding of TIRF images. n > 30 cells
from three independent experiments. ***p < 0.001. Error bars indicate SEM.
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also normalized the increased protrusion speed of cortactin-
KD cells [7] to the level of controls (Figure 1H). Protrusion
distance and retraction speed were not significantly different
between cortactin-manipulated cells in either the absence [7]
or presence of exogenous FN (Figures 1G and 1I). Alterations
in lamellipodial dynamics with OE cells were also equalized
to the level of scrambled controls by plating on 10 mg/ml FN.
HT1080 cells are known to express integrin receptors a2b1
for collagen I, a3b1 for laminin, and a5b1 for FN [15]. Because
cortactin-regulatedmotility was sensitive to the levels of the b1
integrin ligands collagen I and FN, we tested whether b1
expression was altered. The total cellular level of b1 integrin
was similar between control and cortactin-KD cells by western
blot analyses (Figure 2A). In addition, flow cytometry revealed
no differences in cell-surface expression of b1, a2, a3, and a5
integrins (Figure 2B; Figure S2A).We also quantitated the pres-
ence of b1 integrin in adhesions in cortactin-manipulated cells
plated on the non-integrin-binding attachment substrate poly-
D-lysine (PDL) or 10 mg/ml FN by immunostaining fixed, per-
meabilized cells for the presence of total (AIIB2) or activated
(12G10) b1 and imaging the cell-substrate interface with totalinternal reflection fluorescence (TIRF) microscopy. Consistent
with the motility and lamellipodial dynamics results, cortactin-
KD cells had reduced total and activated b1 present in adhe-
sions when plated on PDL, but not on FN (Figure 2; Figure S2).
Analysis of b1 integrin endocytosis exhibited a similar profile,
with an increase in early b1 internalization in cortactin-KD cells
when plated on low but not high FN (2 and 5 min time points,
Figure S2). We speculate that the increased endocytosis of
b1 integrin in cortactin-KD cells plated on low concentrations
of FN is likely due to defective adhesion formation (Figure 2;
Figure S2; [7]), leading to a larger population of unengaged b1
integrins available for endocytosis [16]. Because both the low
adhesion formation and the increase in early b1 endocytosis
were rescued when cortactin-KD cells were plated on high
FNconcentrations, we hypothesize that the primary underlying
defect in cortactin-KD cells is defective secretion of ECM.
Motility Defects of Cortactin-KD Cells Are Due to Defective
Secretion of Autocrine ECM
To directly test the effect of autocrine-produced ECM on
cell motility, we prepared tissue culture plates coated with
cell-free autocrine ECM from cortactin-manipulated HT1080
Figure 3. Autocrine-Produced Extracellular Matrix from Cortactin-Expressing Cells Rescues the Motility Defect of Cortactin-KD Cells
(A and B) Single-cell migration assays of cortactin-manipulated HT1080 (A) and MDA-MB-231 (B) cells plated on cell-free autocrine extracellular matrix
(ECM) derived from control or KD cells as indicated. The following abbreviations are used: Sc, scrambled control; pRS, vector-expressing; KD, cortac-
tin-KD; Res, cortactin-rescued. n > 50 cells from three independent experiments.
(C) Representative images of FN immunostaining of cell-free ECM derived from cortactin-manipulated MDA-MB-231 cells. Scale bar represents 30 mm.
(D) Quantitation of the area per frame and intensity per frame of MDA-MB-231-derived cell-free ECM images. n > 30 images from three independent exper-
iments.
(E and F) Analysis of basally secreted FN in HT1080 cells.
(E) Representative matched DIC and TIRF images from fixed, immunostained cortactin-manipulated HT1080 cells showing a deficit in basal FN underneath
cortactin-KD cells. Scale bar represents 30 mm.
(F) Quantitation of FN-positive area per cell and intensity per cell from TIRF images. nR 25 images from three independent experiments.
*p < 0.05; **p < 0.01; ***p < 0.001 compared to control cells. Error bars indicate SEM.
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before removal of cells with 20 mM ammonium hydroxide
(NH4OH). NH4OH is minimally damaging to autocrine-pro-
duced ECM and leaves many biological properties intact,
including adhesion, spreading, and growth [17]. New cultures
of cortactin-manipulated HT1080s were then plated on the
autocrine-ECM-coated dishes for 2 hr before testing in 5 hr
single-cell motility assays. As predicted, cortactin-KD cell
motility was fully rescued on autocrine ECM extracted from
scrambled and rescue cells, but not on cortactin-KD-derived
autocrine ECM (Figure 3A). However, the motility of scrambled
and rescue cells was similar regardless of the source of auto-
crine ECM, suggesting that cortactin-expressing cells can
sufficiently modulate the ECM environment during the experi-
ment for efficient migration. Cortactin-manipulated MDA-MB-
231 cells responded similarly, with rescue of KD motility on
autocrine-produced ECM from cells expressing cortactin
(Figure 3B).
Immunofluorescent staining for FN in the autocrine-
produced cell-free ECM revealed little detectable deposition
in HT1080-produced ECM; however, FN staining was detect-
able in MDA-MB-231-produced ECM, and there was less FN
deposition in cortactin-KD cell-produced ECM (Figures 3C
and 3D). To verify this finding in a second cell type, we
obtained previously published control and cortactin-KD
mouse embryonic fibroblasts (MEFs) [18] and prepared cell-
free ECM. As expected, there was less FN detected in auto-
crine ECM prepared from cortactin-KD MEFs, compared with
control-derived ECM (Figure S3). We speculate that the
inability to visualize HT1080-produced cell-free FN represents
either a signal-to-noise issue or greater extractability ofHT1080 ECM from glass coverslips by NH4OH, because we
visualized it easily below cortactin-manipulated HT1080 cells
by TIRF microscopy (Figures 3E and 3F). Note also that the
cell motility experiments were performed on autocrine-
produced ECM-coated plastic, and plastic adsorbs ECM
more efficiently than glass [19]. These data indicate that cor-
tactin is critical for FN secretion at the cell-substrate interface.
Cortactin Regulates Secretion of FN from an Endocytic
Compartment
To determine whether changes in FN expression could explain
the decreased FN secretion into cortactin-KD-produced auto-
crine ECM, we performed quantitative RT-PCR and western
blot analyses. No significant differences were observed in total
cell levels of FNmRNA or protein between any of the cortactin-
manipulated cell lines (Figures 4A and 4B), suggesting that
cortactin may instead regulate FN trafficking. Indeed, exami-
nation of permeabilized cells immunostained for FN revealed
that twice as many cortactin-KD cells contained large perinu-
clear FN-containing puncta as compared with control cells
(Figure 4C, top panels), suggesting an exit defect from a secre-
tory compartment.
To identify that compartment, we first tested whether the
major source of secreted FN was exogenous (i.e., the serum
contains significant amounts of FN [20]) as opposed to biosyn-
thetic pathways. Up to this point, all experiments had been
performed in media containing regular serum. To determine
the predominant pathway in our system, we repeated two crit-
ical experiments in media containing FN-depleted serum:
immunostaining of intracellular FN and single-cell motility on
autocrine-produced ECM. For immunostaining, cells were
Figure 4. Internalized Fibronectin Is Used for Motility
(A) Quantitative real-time PCR. Relative FN mRNA abundance was measured by 2-DDCt. n = 3 experiments.
(B) Representative western blot images and analyses of FN protein abundance in total cell lysates. FN intensities were normalized by GAPDH intensities. n =
3 experiments.
(C and D) To analyze intracellular accumulation of ECM, cortactin-manipulated HT1080 cells were cultured in media containing complete bovine growth
serum (BGS) or FN-depleted BGS (DFN) and immunostained for FN.
(C) Representative fluorescence confocal images. Scale bar represents 30 mm.
(D) Percentage of cells with large intracellular FN-positive puncta (R2 mm diameter). nR 200 cells from three independent experiments.
(E) Single-cell migration on cell-free autocrine ECM with FN-depleted BGS-containing media (compare to Figure 3A). nR 50 cells from three independent
experiments.
(F) Representative western blot images from pulse-chase assay performed using poly-HRP-conjugated streptavidin (‘‘biotinylated’’) and FN antibody
(‘‘total’’). Total cell lysates were gathered after the 1 hr pulse to show biotinylated FN uptake. Conditioned media were gathered 24 hr after the pulse chase.
(G) Quantitation of experiments in (F). TCL indicates total cell lysates and represents biotinylated FN signal normalized by the GAPDH loading control. n = 3
experiments.
*p < 0.05; **p < 0.01; ***p < 0.001 compared to control cells. Error bars indicate SEM.
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10% bovine growth serum (BGS) or 10% FN-depleted BGS
(Figure S4) followed by fixation (Figures 4C and 4D). For
motility experiments, cell-free autocrine ECM was prepared
as before, cells were plated in media containing FN-depleted
BGS and equilibrated for 2 hr, and movies were then taken
for 5 hr (Figure 4E). Interestingly, intracellular FN accumulation
in cortactin-KD cells was decreased and equivalent to control
cells upon culturing in FN-depleted BGS (Figures 4C and 4D).
Likewise, single-cell motility of all cortactin-manipulated
HT1080 cells was equivalent and dampened (by almost
2-fold) when the experiment was performed in FN-depleted
BGS (Figure 4E; compare to Figure 3A). These data indicate
that, dependent on cortactin, cells internalize and resecrete
exogenous ECM to facilitate effective migration.
Because our motility experiments indicated that internalized
FN is critical for cortactin-regulated motility, we performed
a pulse-chase experiment to determine whether cortactin
affects resecretion of internalized FN into conditioned media.
HT1080 cells were incubated with 20 mg/ml biotinylated FN
for 1 hr followed by washing and collection of conditioned
medium after 24 hr. Indeed, despite equivalent FN uptake, cor-
tactin-KD cells secreted 2-fold less biotinylated FN into condi-
tioned medium compared with controls (Figures 4F and 4G).
Cortactin Regulates a Late Endosomal/Lysosomal
Secretory Compartment
To determine which secretory compartment is regulated by
cortactin, we colocalized internalized FN with vesicularmarkers associated with recycling endosomes, apicobasal
trafficking, and secretory lysosomes [21]. Whereas there was
little colocalization of FN with Rab8a or Rab11a (Figure S5A),
a substantial proportion of the internalized FN colocalized
with the late endosomal marker Rab7 and the lysosomal
marker LAMP1 (Figures 5A and 5B). Interestingly, cortactin-
KD cells exhibited a significant increase in colocalization of
FN with Rab7-positive and Rab7/LAMP1 double-positive
compartments compared with control cells (Figures 5A and
5B; Figures S5B and S5C). There was also a large increase in
the size of the Rab7 compartment in cortactin-KD cells (Fig-
ure 5C), suggesting a block in secretion from and/or matura-
tion of late endosomes. There was also a small decrease in
the size of the LAMP1-compartment (Figure 5D), suggesting
a shift in the overall late endosomal/lysosomal population
upon cortactin manipulation. Cortactin was also found to
colocalize with Rab7- and LAMP1-positive vesicles (Fig-
ure S5D). Most KD phenotypes, including FN accumulation in
Rab7-positive compartments, were rescued or diminished by
removal of FN from the media (FN-depleted BGS condition,
Figures 5B–5D), consistent with an exogenous source of accu-
mulated FN.
To provide additional evidence that FN derived from the
media and processed by the endocytic system is deposited
at the basal surface of cells, we incubated cells with DyLight
550-conjugated FN and performed live-cell imaging. By
confocal microscopy, DyLight-FN localized to acidic organ-
elles labeled with LysoTracker Green (Figure S5E). By TIRF
microscopy, DyLight-FN was visible in moving vesicles and
Figure 5. Cortactin Promotes Fibronectin Trafficking from
a Late Endosomal/Lysosomal Secretory Compartment
(A–D) Colocalization of FN with vesicular compartments.
(A) Representative confocal images of FN (red), Rab7 (late
endosomes, green), and LAMP1 (lysosomes, blue) triple
staining of cells cultured in complete BGS-containingmedia.
White indicates triple colocalization; magnifications of
boxed areas are shown below. Scale bar represents 30 mm.
(B) Summary graph of FN localization shows accumulation of
FN in a Rab7/LAMP1 double-positive compartment in KD
cells.
(C) Area of Rab7 staining out of total cell area (from single
confocal slices).
(D) Area of LAMP1 confocal staining out of total cell area.
Error bars in (C) and (D) indicate SEM from three independent
experiments (n R 50 cells total). *p < 0.05; ***p < 0.001
compared to control cells.
(E and F) Cortactin is necessary for accumulation of endocy-
tosed DyLight 550-FN at the cell-substrate interface.
(E) Frames from TIRF live-cell imaging sequences taken at
one frame per minute (see also Movie S1 [control] and Movie
[KD]). The first frame of the movie (time 0) has been sub-
tracted from each frame of the time sequence in order to
detect only newly accumulated FN. Note efficient accumula-
tion for Sc as compared to KD cells. DIC images illustrate
confluence of cell monolayers.
(F) Quantitation of live-cell imaging data as in (E). FN accu-
mulation was quantitated as mean fluorescence intensity
beneath ten individual cells from four independent experi-
ments and was significantly different between Sc and KD
cells (p < 0.001, assessed by MatLab analysis of covariance
comparing the two regression lines). Both Sc and KD cells
exhibit constant FN accumulation (line function fitting
confirmed by R2 > 0.9). Slope coefficient is 27.965 for Sc
and 6.56 for KD. Error bars indicate SEM.
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evidenced by progressive accumulation in elongated immo-
bile structures that may represent newly assembling adhe-
sions (Movie S1; Movie S2). In addition, a few of the elongated
structures disappeared before the end of recording, indicating
either that nascent FN deposits were re-endocytosed or that
they represented tethered lysosomes that had not yet fused
with the plasma membrane (Movie S1; Movie S2). Compared
with control cells, there was anw4-fold slower rate of total Dy-
Light-FN accumulation at the base of cortactin-KD cells
(Figures 5E and 5F). Size and shape analyses of the movie
data indicated that KD cells exhibited a significant reductionin the number of all types of FN structures appear-
ing in the TIRF plane, including both large linear
accumulations and small circular objects (Figures
S5F and S5G; Movie S1; Movie S2). These data, in
combination with our finding that in cortactin-KD
cells FN accumulates in an enlarged Rab7-posi-
tive compartment (Figures 5A–5C), suggest that
cortactin is important for trafficking of endocy-
tosed FN to the plasma membrane.
To test the general mechanism of lysosomal
secretion in ECM deposition and cell motility,
shRNA targeting the secretory lysosome fusion
regulator synaptotagmin-7 (Syt7) was expressed
in HT1080 cells. Indeed, similar to cortactin-KD,
Syt7-KD HT1080 cells exhibited decreased basal
FN deposition and decreased motility on
uncoated tissue culture dishes compared with
control cells (Figure 6). Also similar to cortactin-KD cells, the motility of control and Syt7-KD cells was equiva-
lent and increased on 10 mg/ml FN-coated dishes.
Interaction of Cortactin with the Arp2/3 Complex and Actin
Filaments Is Critical for Motility and Secretion Phenotypes
To determine underlying molecular interactions that mediate
cortactin regulation of FN secretion and cell motility, we per-
formed rescue experiments in which cortactin proteins with
mutations in the binding sites for the Arp2/3 complex
(W22A), actin filaments (D4RP), or SH3-domain binding part-
ners (W525K) or in Src (3Y) or Erk (S405A and S418A) phos-
phorylation sites [7, 22–24] were re-expressed in KD cells.
Figure 6. Loss of the Lysosomal Secretion Regulator Synaptotagmin-7 also
Results in Defective Basal Fibronectin Secretion and Motility
(A) Western blot of synaptotagmin-7 (Syt7) expression in control (shGFP)
and Syt7-KD (shSyt7-1 and shSyt7-2) HT1080 cells.
(B) Single-cell migration assays on uncoated (no FN) or FN-coated (FN 10;
10 mg/ml) plates. n R 45 cells for each cell line from three independent
experiments.
(C) Representative matched DIC and TIRF images from fixed, immuno-
stained Syt7-manipulated HT1080 cells showing a deficit of basal FN under-
neath Syt7-KD cells. Cell boundaries are outlined in white in TIRF images.
Scale bar represents 30 mm.
(D) Quantitation of basal FN-positive area per cell or intensity per cell with
(w/) or without (w/o) thresholding. n > 30 cells from three independent
experiments.
**p < 0.01; ***p < 0.001 compared to shGFP control. Error bars indicate
SEM.
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KD cells were rescued by re-expression of W525K and 3Y
mutants (Figure 7; Figure S6). The rescue by W525K was
frequently not to the level of that by wild-type cortactin or
3Y, although the differences were not statistically significant.
Conversely, KD defects were not rescued by W22A, D4RP,S405A, or S418A in either assay. Analysis of intracellular accu-
mulation of large FN puncta yielded similar results, except that
theErkmutants also rescuedKDdefects in this assay (Figure 7;
Figure S6). Our interpretation of these results is that the most
critical activity of cortactin in FN secretion and cell motility is
to regulate branched actin networks. A secondary (nonessen-
tial) activity may be to recruit or otherwise interact with SH3
binding partners at those networks.
Discussion
Cortactin regulates cell migration; however, diverse underlying
mechanisms have been proposed. In this study, we report the
novel finding that cortactin regulates extrinsic rather than
intrinsic mechanisms of cell motility by promoting ECM secre-
tion from a late endosomal/lysosomal compartment (see
model in Figure 7E). Consistent with lysosomal secretion of
ECM as a critical regulatory point for cell motility, cortactin-
KD motility and secretion defects were phenocopied by KD
of the late endosomal/lysosomal fusion regulator Syt7. Cortac-
tin functions inmotility and secretion were dependent on inter-
action with branched actin networks but not the SH3 domain.
Cortactin has been intensively studied as a motility factor
since the discovery that it can serve as a cofactor for Arp2/3
activation as well as a stabilizer of actin branches [25, 26].
Numerous studies have demonstrated that cortactin promotes
cell motility as well as proteolytic invasion through ECM [3].
However, conflicting results between studies suggest
context-dependent cortactin functions. For example, several
studies have reported no effect of cortactin loss on cell migra-
tion [6] or lamellipodial architecture [8]. Interestingly, the cell
migration and electron microscopy studies in those reports
were respectively performed using cells plated on 10 mg/ml
[6] and 50 mg/ml [8] FN. Consistent with those results, we
find that cortactin-KD cell defects in motility and lamellipodial
dynamics are fully rescued to the level of control cells upon
plating on similar concentrations of ECM. Our discovery that
cortactin regulates cell motility by promoting ECM deposition
provides a unifying mechanism that explains disparate litera-
ture findings and links reported cortactin functions in motility
and membrane trafficking.
Through mutant rescue studies, we tested the requirements
for keymolecular interactions in cortactin regulation of FN traf-
ficking and cell motility. Consistent with our previous report
[7], we find that cortactin binding to the Arp2/3 complex and
actin filaments is essential for rescue of all phenotypes. The
other sites examined were in the C terminus and regulate
binding of additional partners. Neither the SH3 domain, which
binds most known cortactin binding partners, or the Src/Abl
phosphosites, which create an SH2 binding domain when
phosphorylated [3] and are thought to negatively regulate
the SH3 domain [23], were required for rescue of any cortac-
tin-KD phenotype. These data were somewhat surprising
because several SH3-domain binding partners are good
candidates for regulating vesicle trafficking, including the pin-
chase dynamin 2, the cdc42GEFFgd1, and the Arf GAPASAP1
[3]. By contrast, intact Erk phosphorylation sites are required
for rescue of motility [27] and FN deposition, suggesting that
Erk phosphorylation may regulate more cortactin functions
than just SH3-domain accessibility [23, 28]. Based on the
requirement for intact Arp2/3- and F-actin binding domains
but not SH3-domain binding partners, we speculate that the
truly essential role of cortactin in ECM trafficking is to regulate
branched actin networks at late endosomes or at docking sites
Figure 7. Binding of Cortactin to the Arp2/3
Complex and Actin Filaments Is Critical for Cell
Motility and ECM Secretion
(A) Cortactin domain structuremarkedwithmuta-
tion sites: W22, critical Arp2/3 complex binding
residue; NTA, N-terminal acidic domain; 4RP,
F-actin binding domain; S405 andS418, Erkphos-
phorylation sites; YYY, Srk phosphorylation sites;
SH3, Src homology 3 domain. Ovals represent
cortactin repeat domains. Mutation of the W525
residue prevents binding to the SH3 domain.
(B) Quantitation of transwell migration assays of
cortactin mutant-rescued cells on low (1 mg/ml)
or high (10 mg/ml) FN coating concentrations.
Four fields per filter were observed in each of
four independent experiments.
(C) Quantitation of area per cell and intensity per
cell of deposited FN from TIRF images (represen-
tative DIC and TIRF images are shown in Fig-
ure S6B). n R 25 images per cell line from three
experiments.
(D) The percentage of cells with large intracellular
FN accumulations (R2 mm diameter puncta) was
quantitated from wide-field images (see Fig-
ure S6C for representative images). nR 80 cells
from three independent experiments.
(E) Model of cortactin regulation of ECM deposi-
tion and cell motility. ECM (and potentially other
motility molecules such as integrins) is internal-
ized and resecreted from a late endosomal/
lysosomal compartment to support cell motility.
Cortactin regulation of branched actin networks
is likely to be critical for either the generation or
docking of ECM-containing secretory carriers
derived from a Rab7/LAMP1-positive compart-
ment, whereas Syt7 regulates vesicle fusion at
the plasma membrane. The proposed model in
which cortactin-mediated secretion of ECM leads
to adhesion formation, lamellipodial stability, and
cell motility links known cortactin functions but
provides an alternate mechanism to the current
model in which lamellipodial dynamics drive cell
motility.
*p < 0.05; **p < 0.01; ***p < 0.001 compared to
rescue (Res). Error bars indicate SEM.
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1467for secretory endosomal/lysosomal carriers. Binding of SH3-
domain partners by cortactin might contribute to cortactin-
regulated vesicular trafficking events (e.g., fission or fusion)
but may not be essential if a stable actin network in conjunc-
tion with membrane-bound signaling factors is sufficient to
assemble the required multiprotein trafficking complexes.A somewhat surprising finding from
this study is that cortactin-KD does not
inhibit endocytosis of b1 integrin or,
apparently, FN. A number of studies
have examined the role of cortactin in
endocytosis, and most have found that
KD or inhibition of cortactin reduces en-
docytic rates [29–36]. However, the vast
majority of those studies examined cla-
thrin-dependent endocytosis, and b1 in-
tegrin has been reported to undergo cla-
thrin-independent, lipid-raft-dependent
endocytosis [16, 37]. Although cortactin
has also been reported to regulate cla-
thrin-independent endocytosis [32, 34],
b1 integrin has not been previouslyexamined as a cargo, and there are multiple clathrin-indepen-
dent pathways [37]. Furthermore, cortactin likely does not
affect all endocytic events, because dextran uptake is appar-
ently unperturbed by cortactin inhibition [30].
A key finding of this study is that FN that is internalized,
processed, and resecreted via a late endocytic/lysosomal
Current Biology Vol 21 No 17
1468compartment is reused as a motility substrate. Lysosomally
processed FN may be particularly potent as a substrate,
because partial degradation of FN can yield fragments with
increased adhesiveness [38], and the lysosomal proteinase
cathepsin produces biologically active fragments of FN [39].
To directly test this potential mechanism, we knocked
down the lysosomal fusion regulator Syt7. Indeed, KD of
Syt7 phenocopied cortactin-KD and inhibited both basal FN
secretion and cell motility. Interestingly, a recent report
implicated Syt7-mediated lysosomal secretion in leukocyte
chemotaxis, and another study described regulation of
epithelial cell migration by the late endosomal/lysosomal
v-SNARE VAMP7 [40, 41], suggesting that this mechanism
of motility regulation may be general. Both studies showed
localization of lysosomal markers at lamellipodia, consistent
with exocytosis occurring at the leading edge of migrating
cells.
Althoughwe focused on fibronectin secretion in this study, it
is likely that the same vesicular carriers contain other motility-
regulating molecules (Figure 7E). Indeed, integrins may be
cosecreted with their ligands, because a5b1 integrin-FN
cotrafficking through multivesicular bodies to lysosomes
was recently shown to be important for cell migration [42].
Consistent with that idea, in our b1 integrin endocytosis
assays, the only change in KD cells that was not rescued by
plating on high FNwas intracellular accumulation of b1 integrin
at the late 15 min time point, suggesting a block in late endo-
somal trafficking. It is also possible that newly synthesized
motility molecules may be secreted via the same pathway,
because post-Golgi packaging can occur in endosomes and
secretory lysosomes [43, 44].
In light of our findings, how do we consider the role of cor-
tactin throughout the cell? Cortactin is one of the best markers
of branched actin at various cellular sites and is particularly
popular as a marker for branched-actin-rich lamellipodia and
invadopodia [2]. Given the affinity of cortactin for the Arp2/3
complex [25] and newly polymerized actin [7] and the cooper-
ative regulation of branched actin assembly noted by many
investigators [26, 45–48], it seems likely that cortactin does
regulate branched actin in lamellipodia and elsewhere. In
fact, cortactin has been shown to affect cell edge protrusion
during initial cell spreading on ECM-coated substrates [18],
suggesting that cortactin does indeed regulate branched actin
dynamics within cellular protrusions [7, 8, 49]. However, we
found that interaction of cortactin with the Arp2/3 complex
and F-actin is also required for FN secretion, suggesting that
regulation of exocytosis is a key consequence of cortactin
action on branched actin networks that promotes migration
and invasion [3].
Experimental Procedures
Cell Culture and Gene Manipulation
HT1080 cell lines, knockdown and rescue constructs, and motility and
lamellipodial dynamics assays were as described previously [7]. Cortactin
mutants were gifts from Thomas Parson (University of Virginia) and were
cloned into LZRS retroviral vector. A lentiviral shRNA expression system,
pLKO.1, was used to knock down synaptotagmin-7 (Open Biosystems
RHS3979-9577052 for KD-1 and RHS3979-9577053 for KD-2) or GFP
(Sigma-Aldrich SHC005) in HT1080 cells.
Antibodies and Reagents
Anti-b1 (12G10 for flow cytometry and M-106 for western blots), anti-a2
(P1E6), anti-a3 (P1B5), and anti-a5 (P1D6) integrin antibodies and normal
mouse IgG1 isotype control for fluorescence-activated cell sorting (sc-
3877), anti-FN rabbit polyclonal (H-300 used in the triple staining withRab7 and LAMP1 antibodies), and anti-Rab7 (goat, A-16) antibodies were
from Santa Cruz Biotechnology. Anti-cortactin mouse monoclonal (4F11,
Upstate) and rabbit polyclonal (H-191, Santa Cruz Biotechnology), anti-
b-actin (Ac-74, Sigma), anti-GAPDH (14C10, Cell Signaling), anti-FN mouse
monoclonal (610077, used in TIRF and intracellular accumulation assays),
anti-EEA1 (610456), and anti-CD107a (LAMP1, mouse, 555798) (BD Trans-
duction Laboratories) antibodies were purchased from the listed manufac-
turers. Anti-b1 integrin rat monoclonal antibody (AIIB2) was a gift from Roy
Zent (Vanderbilt University). Anti-Rab8a and anti-Rab11a antibodies were
gifts from James Goldenring (Vanderbilt University). Anti-synaptotagmin 7
antibody (105 173) was from Synaptic Systems. Alexa Fluor-conjugated
secondary antibodies were from Invitrogen. Human plasma FN was from
GIBCO BRL, and human collagen type I was from Sigma. DyLight 550
NHS ester (62262) and EZ-Link sulfo-NHS-LC-LC-biotin (21338) were from
Thermo Scientific and were conjugated to FN following the manufacturer’s
instructions. LysoTracker Green DND-26 (L-7526) was from Molecular
Probes.
Statistical Analyses
All statistical analyses were performed using Student’s t test and calculated
by Microsoft Excel software, except for the live TIRF imaging, for which
statistical analysis was performed using MatLab.
For more materials and methods, see Supplemental Experimental
Procedures.
Supplemental Information
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and two movies and can be found with this article online at
doi:10.1016/j.cub.2011.06.065.
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